emibetuzumab   

GtoPdb Ligand ID: 7748

Synonyms: LA480 | LY-2875358 | LY2875358
Compound class: Antibody
Comment: Emibetuzumab is an investigatonal monoclonal antibody designed as a potential treatment for advanced or metastatic solid tumors.
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record.
Bioactivity Comments
Peptide sequence alignment suggests that emibetuzumab is antibody C8-H241 in patent US8217148 [1]. The binding data mapped to this antibody is derived from this patent.
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
MET proto-oncogene, receptor tyrosine kinase Hs Antibody Binding >10.0 pKd - 1
pKd >10.0 (Kd <1x10-10 M) [1]
Description: binding constant for hMET extracellular domain measured using proprietary BIACore® technology